Cite
HARVARD Citation
Siebert, S. et al. (n.d.). 245 Remission/low disease activity is an achievable treatment target in psoriatic arthritis (PsA): results from a routine care European cohort of PsA patients treated with ustekinumab or TNF inhibitors. Rheumatology. p. . [Online].